The Study of INitial choice of DPP-4i in Japanese T2DM patients: Effects of Linagliptin on QOL
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Linagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INTEL-QOL
- 03 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Feb 2017 Status changed from not yet recruiting to recruiting.
- 15 Jul 2016 New trial record